Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. USO
4. KBH
5. HTZ
6. QCOM
7. SPY
8. HON
9. SPCX
10. TTWO

Go back to Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Lineage Cell Therapeutics (LCTX) Misses Q4 EPS by 12c

March 10, 2022 4:30 PM EST

Lineage Cell Therapeutics (NYSE: LCTX) reported Q4 EPS of ($0.17), $0.12 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $640 thousand.

For earnings history and earnings-related data on Lineage Cell Therapeutics (LCTX) click here.

... More